Drug Shortage Report for TOPOTECAN HYDROCHLORIDE FOR INJECTION

Last updated on 2017-08-30 History
Report ID 14854
Drug Identification Number 02379422
Brand name TOPOTECAN HYDROCHLORIDE FOR INJECTION
Common or Proper name Topotecan
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) TOPOTECAN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 x 4mL
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-07-12
Actual start date
Estimated end date 2017-08-30
Actual end date 2017-08-29
Shortage status Resolved
Updated date 2017-08-30
Company comments Resolved August 29, 2017
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2017-08-30 French Compare
v12 2017-08-30 English Compare
v11 2017-08-30 English Compare
v10 2017-08-28 French Compare
v9 2017-08-28 English Compare
v8 2017-07-19 French Compare
v7 2017-07-19 English Compare
v6 2017-07-13 English Compare
v5 2017-07-06 French Compare
v4 2017-07-06 English Compare
v3 2017-07-06 French Compare
v2 2017-07-06 English Compare
v1 2017-07-06 English Compare

Showing 1 to 13 of 13